Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-06, Stock:NVS, The news for the past five days is as follows:
2018-02-27: NEWS1: TTOO Gains Steam, LPCN Up On Upgrade, ALDX Abuzz.NEWS2: TTOO Gains Steam, LPCN Up On Upgrade, ALDX Abuzz.NEWS3: Lilly's Verzenio Wins FDA Nod for First Line Breast Cancer.NEWS4: Lilly's Verzenio Wins FDA Nod for First Line Breast Cancer.NEWS5: JNJ’s Cardiovascular Segment’s Performance in 4Q17 and 2017.NEWS6: 5 Things Exelixis Inc. Management Wants You to Know About the Biotech's Future.NEWS7: 5 Things Exelixis Inc. Management Wants You to Know About the Biotech's Future.NEWS8: Large and Small: Here’s What’s Moving Eli Lilly and Zosano.NEWS9: The Swiss Stock Market Pulled Back Below 9,000 Points.NEWS10: The Swiss Stock Market Pulled Back Below 9,000 Points.
2018-02-28: NEWS1: Ophthotech (OPHT) Q4 Earnings Beat, Gene Therapy in Focus.NEWS2: Ophthotech (OPHT) Q4 Earnings Beat, Gene Therapy in Focus.NEWS3: The Swiss Stock Market Pulled Back On Powell Comments.NEWS4: The Swiss Stock Market Pulled Back On Powell Comments.NEWS5: [$$] Fight against leprosy is far from over.
2018-03-01: NEWS1: Performance of Sanofi’s Business Segments in 4Q17.NEWS2: Amgen (AMGN) Gets CHMP Nod to Expand EU Label of Neulasta.NEWS3: Amgen (AMGN) Gets CHMP Nod to Expand EU Label of Neulasta.NEWS4: Aerie's (AERI) Q4 Loss Wider on Higher Operating Expenses.NEWS5: Aerie's (AERI) Q4 Loss Wider on Higher Operating Expenses.NEWS6: The Swiss Stock Market Extended Its Losing Streak.NEWS7: The Swiss Stock Market Extended Its Losing Streak.NEWS8: Novartis, Pear Therapeutics To Develop Digital Therapeutics For Schizophrenia.NEWS9: Novartis, Pear Therapeutics To Develop Digital Therapeutics For Schizophrenia.
2018-03-02: NEWS1: Wall Street More Optimistic about Johnson & Johnson after 4Q17.NEWS2: Sanofi’s Generics and Consumer Healthcare Portfolios in 4Q17.NEWS3: Sanofi’s Established Prescription Products in 4Q17.NEWS4: Novartis Shareholders Approve All Resolutions At AGM - Quick Facts.NEWS5: Novartis Shareholders Approve All Resolutions At AGM - Quick Facts.
2018-03-05: NEWS1: Bullish Two Hundred Day Moving Average Cross - NVS.NEWS2: Bullish Two Hundred Day Moving Average Cross - NVS.NEWS3: Here's Why Dermira Fell as Much as 64.2% Today.NEWS4: Here's Why Dermira Fell as Much as 64.2% Today.NEWS5: Aduro (ADRO) Q4 Loss Narrower Than Expected, Revenues Miss.NEWS6: Aduro (ADRO) Q4 Loss Narrower Than Expected, Revenues Miss.NEWS7: Noteworthy ETF Inflows: VEA, NSRGY, NVS, RDS.B.NEWS8: Noteworthy ETF Inflows: VEA, NSRGY, NVS, RDS.B.NEWS9: What's in Store for Conatus (CNAT) This Earnings Season?.NEWS10: What's in Store for Conatus (CNAT) This Earnings Season?.NEWS11: Greek parliament set to probe politicians in alleged Novartis bribery case.NEWS12: Sanofi’s Valuations in February 2018.NEWS13: Johnson & Johnson Stock: What’s behind the Recent Decline?.NEWS14: The Swiss Stock Market Staged A Strong Recovery.NEWS15: The Swiss Stock Market Staged A Strong Recovery.

Answer: Decrease